title: Acute myocardial infarction associated with thinner abuse: case report and literature review.
authors.forename: Yalcin
authors.initials: Y
authors.lastname: Velibey
authors.forename: Servet
authors.initials: S
authors.lastname: Altay
authors.forename: Sait
authors.initials: S
authors.lastname: Terzi
authors.forename: Kemal
authors.initials: K
authors.lastname: Yesilcimen
authors.forename: Yalcin
authors.initials: Y
authors.lastname: Golcuk
authors.forename: Erkan
authors.initials: E
authors.lastname: Gunay
mesh_terms: D000293:Adolescent; D000328:Adult; D015415:Biomarkers / Q000097:blood; D001780:Blood Coagulation Tests; D017023:Coronary Angiography; D052279:Creatine Kinase, MB Form / Q000097:blood; D004562:Electrocardiography; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D007262:Infusions, Intravenous; D019570:Inhalation Exposure / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D010979:Platelet Function Tests; D011237:Predictive Value of Tests; D012997:Solvents / Q000009:adverse effects*; D019966:Substance-Related Disorders / Q000150:complications*; D013997:Time Factors; D000077466:Tirofiban; D016896:Treatment Outcome; D019210:Troponin I / Q000097:blood; D014443:Tyrosine / Q000008:administration & dosage / Q000031:analogs & derivatives; D015854:Up-Regulation; D055815:Young Adult
chemical_list: D015415:Biomarkers; D005343:Fibrinolytic Agents; D012997:Solvents; D019210:Troponin I; D014443:Tyrosine; D052279:Creatine Kinase, MB Form; D000077466:Tirofiban